Corrigendum to: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases, (Front. Immunol, (2022), 13, (865241), 10.3389/fimmu.2022.865241)

Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, Mayumi Kamaguchi, Colin Osterloh, Manuela Pigors, Natalie Gross, Stanislav Khil’chenko, Anika Kasprick, Sabrina Patzelt, Diana Wortmann, Ibrahim O. Ibrahim, Kentaro Izumi, Stephanie Goletz, Katharina Boch, Kathrin Kalies, Katja Bieber, Paul Smith, Enno Schmidt, Ralf J. Ludwig*

*Corresponding author for this work
2 Citations (Scopus)


In the published article, there was an error in the author list. The equal contribution of Saeedeh Ghorbanalipoor, Shirin Emtenani as first authors and that of Enno Schmidt and Ralf J. Ludwig as last authors had not been indicated. The corrected author list appears below.

Original languageEnglish
Article number1099535
JournalFrontiers in Immunology
Publication statusPublished - 30.11.2022

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)
  • Centers: Center for Research on Inflammation of the Skin (CRIS)

DFG Research Classification Scheme

  • 204-05 Immunology
  • 205-19 Dermatology

Cite this